(Cleveland) - University Hospitals is taking part in a study to help prove something that has been done on an experimental basis in other hospitals. That would be using the blood plasma of people who have recovered from COVID-19, and giving that plasma to hospitalized COVID-19 patients to build up their antibodies to the virus.
Since there is no FDA-approved medicine to treat or prevent the virus, some hospitals have tried this experimental treatment.
Dr. Steven Filby, a cardiologist at UH who will be one of the investigators in the study, says, "UH is at the forefront of experimental treatments including remdesivir, stem cell therapy, and now, convalescent plasma. Patients suffering from extreme complications of COVID-19 have hope at UH, thanks to these options."
The study is headed up by The Christ Hospital in Cincinnati. UH is one of three sites in Ohio taking part in the study.
(Photo Courtesy University Hospitals)
(Copyright, 2020, iHeartMedia)